These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15455788)

  • 1. [Physiological effects of C-peptide].
    Tsimaratos M
    Nephrologie; 2004; 25(5):155-61. PubMed ID: 15455788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiological effects of the connecting peptide].
    Tsimaratos M
    Arch Pediatr; 2005 Apr; 12(4):442-8. PubMed ID: 15808437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
    Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
    Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cellular effects of C-peptide--new perspectives on an old peptide.
    Wahren J; Shafqat J; Johansson J; Chibalin A; Ekberg K; Jörnvall H
    Exp Diabesity Res; 2004; 5(1):15-23. PubMed ID: 15198368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide.
    Sima AA
    J Neurol Sci; 2004 May; 220(1-2):133-6. PubMed ID: 15140622
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of C-peptide on microvascular blood flow and blood hemorheology.
    Forst T; Kunt T
    Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats.
    Kamikawa A; Ishii T; Shimada K; Makondo K; Inanami O; Sakane N; Yoshida T; Saito M; Kimura K
    Diabetes Metab Res Rev; 2008; 24(4):331-8. PubMed ID: 18088079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide makes a comeback.
    Wahren J; Jörnvall H
    Diabetes Metab Res Rev; 2003; 19(5):345-7. PubMed ID: 12951641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
    Djemli-Shipkolye A; Gallice P; Coste T; Jannot MF; Tsimaratos M; Raccah D; Vague P
    Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Maurice Dérot Prize 2004. Should C-peptide be put in the insulin bottle?].
    Vague P
    Journ Annu Diabetol Hotel Dieu; 2004; ():231-7. PubMed ID: 15259321
    [No Abstract]   [Full Text] [Related]  

  • 12. New aspects on biological activity of C-peptide in IDDM patients.
    Forst T; Kunt T; Pfützner A; Beyer J; Wahren J
    Exp Clin Endocrinol Diabetes; 1998; 106(4):270-6. PubMed ID: 9792458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological effects of proinsulin C-peptide].
    Kimura K
    Seikagaku; 2005 May; 77(5):419-23. PubMed ID: 15952332
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracellular signalling by C-peptide.
    Hills CE; Brunskill NJ
    Exp Diabetes Res; 2008; 2008():635158. PubMed ID: 18382618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus.
    Kunt T; Schneider S; Pfützner A; Goitum K; Engelbach M; Schauf B; Beyer J; Forst T
    Diabetologia; 1999 Apr; 42(4):465-71. PubMed ID: 10230651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proinsulin C-peptide -- the bioactive peptide with a huge promise].
    Walenciak Ł; Fendler W; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2007; 13(2):95-8. PubMed ID: 17880815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of C-peptide on early glomerular changes in diabetic mice.
    Maezawa Y; Yokote K; Sonezaki K; Fujimoto M; Kobayashi K; Kawamura H; Tokuyama T; Takemoto M; Ueda S; Kuwaki T; Mori S; Wahren J; Saito Y
    Diabetes Metab Res Rev; 2006; 22(4):313-22. PubMed ID: 16389646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 diabetic neuropathy and C-peptide.
    Sima AA; Zhang W; Grunberger G
    Exp Diabesity Res; 2004; 5(1):65-77. PubMed ID: 15198372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-Peptide effects on renal physiology and diabetes.
    Rebsomen L; Khammar A; Raccah D; Tsimaratos M
    Exp Diabetes Res; 2008; 2008():281536. PubMed ID: 18509500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-peptide as a therapeutic tool in diabetic nephropathy.
    Hills CE; Brunskill NJ; Squires PE
    Am J Nephrol; 2010; 31(5):389-97. PubMed ID: 20357430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.